Human immunodeficiency virusassociated cytomegalovirus infection with multiple small vessel cerebral infarcts in the setting of early immune reconstitution

Journal of NeuroVirology

Volumn 16, Issue 2, 2010, Pages 179-184

  Anderson, Albert M ^a   Fountain, Jack A ^a   Green, Sonya B ^b   Bloom, Sharon A ^c   Palmore, Melody P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GRADY HEALTH SYSTEM   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

AIDS; Cytomegalovirus; HIV

Indexed keywords

DARUNAVIR PLUS RITONAVIR; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; FOSCARNET; GANCICLOVIR; IMMUNOGLOBULIN G; VALGANCICLOVIR; VIRUS DNA; VIRUS RNA; ANTIVIRUS AGENT;

ADULT; ARTICLE; BRAIN INFARCTION; BRAIN VASCULITIS; CAPSULA INTERNA; CASE REPORT; CAUDATE NUCLEUS; CD4+ T LYMPHOCYTE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; CYTOMEGALOVIRUS RETINITIS; DIFFUSION COEFFICIENT; DISEASE ASSOCIATION; DRUG RESPONSE; ENDOTHELIUM CELL; GENE MUTATION; GENOTYPE; GLOBUS PALLIDUS; GRIP STRENGTH; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LIMB WEAKNESS; LYMPHOCYTE COUNT; MALE; MICROVASCULATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINA HEMORRHAGE; VASCULAR ENDOTHELIUM; VIRUS LOAD; VISUAL IMPAIRMENT; WEAKNESS; PATHOPHYSIOLOGY; VIROLOGY;

CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; CEREBRAL INFARCTION; CYTOMEGALOVIRUS RETINITIS; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MAGNETIC RESONANCE IMAGING; MALE; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 77952201778     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550281003735717     Document Type: Article

References (26)

1. Anduze-Faris BM, Fillet AM, Gozlan J, et al. (2000). Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients. AIDS 14: 517-524.
2. Arribas JR, Storch GA, Clifford DB, Tselis AC (1996). Cytomegalovirus encephalitis. Ann Intern Med 125: 577-587.
3. Berman SM, Kim RC (1994). The development of cytomeg-alovirus encephalitis in AIDS patients receiving ganci-clovir. Am J Med 96: 415-419.
4. Bonkowsky JL, Christenson JC, Nixon GW, Pavia AT (2002). Cerebral aneurysms in a child with acquired immune deficiency syndrome during rapid immune reconstitution. J Child Neurol 17: 457-460.
5. Crowe SM, Carlin JB, Stewart KI, Lucas CR, Hoy JF (1991). Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr 4: 770-776.
6. Dobbs MR, Berger JR (2009). Stroke in HIV infection and AIDS. Expert Rev Cardiovasc Ther 7: 1263-1271.
7. Duna GF, Calabrese LH (1995). Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system. J Rheumatol 22: 662-667.
8. Fish KN, Soderberg-Naucler C, Mills LK, Stenglein S, Nelson JA (1998). Human cytomegalovirus persistently infects aortic endothelial cells. J Virol 72: 5661-5668.
9. French MA (2009). HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis 48: 101-107.
10. Gilden DH, Kleinschmidt-DeMasters BK, Wellish M, Hedley-Whyte ET, Rentier B, Mahalingam R (1996). Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited. Neurology 47: 1441-1446.
11. Kieburtz KD, Eskin TA, Ketonen L, Tuite MJ (1993). Opportunistic cerebral vasculopathy and stroke in patients with the acquired immunodeficiency syndrome. Arch Neurol 50: 430-432.
12. Klatt EC, Shibata D (1988). Cytomegalovirus infection in the acquired immunodeficiency syndrome. Clinical and autopsy findings. Arch Pathol Lab Med 112: 540-544.
13. Koeppen AH, Lansing LS, Peng SK, Smith RS (1981). Central nervous system vasculitis in cytomegalovirus infection. J Neurol Sci 51: 395-410.
14. Kofteridis DP, Repa A, Anastasopoulos T, et al. (2007). A case of human immunodeficiency virus infection disclosed by cytomegalovirus encephalitis. Int J Infect Dis 11: 373-375.
15. Kossorotoff M, Touze E, Godon-Hardy S, et al. (2006). Cerebral vasculopathy with aneurysm formation in HIV-infected young adults. Neurology 66: 1121-1122.
16. Melica G, Brugieres P, Lascaux AS, Levy Y, Lelievre JD (2009). Primary vasculitis of the central nervous system in patients infected with HIV-1 in the HAART era. J Med Virol 81: 578-581.
17. Morgello S, Cho ES, Nielsen S, Devinsky O, Petito CK (1987). Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: an autopsy study of 30 cases and a review of the literature. Hum Pathol 18: 289-297.
18. Nagel MA, Cohrs RJ, Mahalingam R, et al. (2008). The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology 70: 853-860. (Pubitemid 351367506)
19. Newsome SD, Nath A (2009). Varicella-zoster virus vasculopathy and central nervous system immune reconstitution inflammatory syndrome with human immunodeficiency virus infection treated with steroids. J NeuroVirol 15: 1-4.
20. Patel AK, Patel KK, Shah SD, Desai J (2006). Immune reconstitution syndrome presenting with cerebral varicella zoster vasculitis in HIV-1-infected patient: a case report. J Int Assoc Physicians AIDS Care 5: 157-160.
21. Ridker PM, Hennekens CH, Stampfer MJ, Wang F (1998). Prospective study of herpes simplex virus, cytomegalo-virus, and the risk of future myocardial infarction and stroke. Circulation 98: 2796-2799.
22. Shelburne SA III, Hamill RJ, Rodriguez-Barradas MC, et al. (2002). Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy. Medicine (Baltimore) 81: 213-227.
23. Sinzger C, Grefte A, Plachter B, Gouw AS, The TH, Jahn G (1995). Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol 76(Pt 4): 741-750.
24. Sklar PA, Agyemang AF, Monastra R, et al. (2004). Five-year follow-up of a cohort of profoundly immunosup-pressed patients discontinuing therapy for cytomegalo-virus retinitis. AIDS 18: 567-569.
25. Tunkel AR, Glaser CA, Bloch KC, et al. (2008). The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 47: 303-327.
26. Waldman WJ, Knight DA, Huang EH, Sedmak DD (1995). Bidirectional transmission of infectious cytomega-lovirus between monocytes and vascular endo-thelial cells: an in vitro model. J Infect Dis 171: 263-272.